Form 8-K - Current report:
SEC Accession No. 0001104659-25-021990
Filing Date
2025-03-10
Accepted
2025-03-10 08:30:20
Documents
30
Period of Report
2025-03-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm258686d1_8k.htm   iXBRL 8-K 27714
2 EXHIBIT 99.1 tm258686d1_ex99-1.htm EX-99.1 17797
3 EXHIBIT 99.2 tm258686d1_ex99-2.htm EX-99.2 22071
7 GRAPHIC tm258686d1_ex99-1img001.jpg GRAPHIC 2943
8 GRAPHIC tm258686d1_ex99-2img001.jpg GRAPHIC 144917
9 GRAPHIC tm258686d1_ex99-2img002.jpg GRAPHIC 143364
10 GRAPHIC tm258686d1_ex99-2img003.jpg GRAPHIC 193550
11 GRAPHIC tm258686d1_ex99-2img004.jpg GRAPHIC 202786
12 GRAPHIC tm258686d1_ex99-2img005.jpg GRAPHIC 179884
13 GRAPHIC tm258686d1_ex99-2img006.jpg GRAPHIC 161895
14 GRAPHIC tm258686d1_ex99-2img007.jpg GRAPHIC 193521
15 GRAPHIC tm258686d1_ex99-2img008.jpg GRAPHIC 132502
16 GRAPHIC tm258686d1_ex99-2img009.jpg GRAPHIC 162835
17 GRAPHIC tm258686d1_ex99-2img010.jpg GRAPHIC 144056
18 GRAPHIC tm258686d1_ex99-2img011.jpg GRAPHIC 141839
19 GRAPHIC tm258686d1_ex99-2img012.jpg GRAPHIC 152836
20 GRAPHIC tm258686d1_ex99-2img013.jpg GRAPHIC 112150
21 GRAPHIC tm258686d1_ex99-2img014.jpg GRAPHIC 165914
  Complete submission text file 0001104659-25-021990.txt   3336531

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA alms-20250308.xsd EX-101.SCH 3009
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE alms-20250308_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alms-20250308_pre.xml EX-101.PRE 22355
32 EXTRACTED XBRL INSTANCE DOCUMENT tm258686d1_8k_htm.xml XML 3679
Mailing Address 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 650-231-6625
ALUMIS INC. (Filer) CIK: 0001847367 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42143 | Film No.: 25722275
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)